Scientific publications
Revisiting intracavitary immunotherapy of cancer
Fernando Aranda 1 , Iñaki Eguren-Santamaria 2 , Angela Bella 1 , Pedro Berraondo 1 , Ignacio Melero 3
Abstract
Ovarian cancer is often limited to the peritoneal cavity in the form of peritoneal carcinomatosis. Peritoneal spreading offers the opportunity for locoregional delivery of combinations of immunotherapy agents, maximizing bioavailability while potentially reducing systemic exposure and side effects.
CITATION Clin Cancer Res. 2022 May 13;28(10):1993-1995.
doi: 10.1158/1078-0432.CCR-22-0201.

Our authors

